| Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma A Jayachandran, B Dhungel, JC Steel Journal of hematology & oncology 9, 1-12, 2016 | 189 | 2016 |
| Transgelin is a direct target of TGF‐β/Smad3‐dependent epithelial cell migration in lung fibrosis H Yu, M Königshoff, A Jayachandran, D Handley, W Seeger, N Kaminski, ... The FASEB Journal 22 (6), 1778-1789, 2008 | 174 | 2008 |
| Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma A Jayachandran, M Anaka, P Prithviraj, C Hudson, SJ McKeown, PH Lo, ... Oncotarget 5 (14), 5782, 2014 | 138 | 2014 |
| Monitoring immune checkpoint regulators as predictive biomarkers in hepatocellular carcinoma R Shrestha, P Prithviraj, M Anaka, KR Bridle, DHG Crawford, B Dhungel, ... Frontiers in oncology 8, 269, 2018 | 131 | 2018 |
| Leukocytes induce epithelial to mesenchymal transition after unilateral ureteral obstruction in neonatal mice B Lange-Sperandio, A Trautmann, O Eickelberg, A Jayachandran, ... The American journal of pathology 171 (3), 861-871, 2007 | 115 | 2007 |
| SNAI transcription factors mediate epithelial–mesenchymal transition in lung fibrosis A Jayachandran, M Königshoff, H Yu, E Rupniewska, M Hecker, ... Thorax 64 (12), 1053-1061, 2009 | 112 | 2009 |
| Dual targeting of bromodomain and extraterminal domain proteins, and WNT or MAPK signaling, inhibits c-MYC expression and proliferation of colorectal cancer cells L Tögel, R Nightingale, AC Chueh, A Jayachandran, H Tran, T Phesse, ... Molecular cancer therapeutics 15 (6), 1217-1226, 2016 | 98 | 2016 |
| Epithelial-to-mesenchymal transition: A mediator of sorafenib resistance in advanced hepatocellular carcinoma N Mir, A Jayachandran, B Dhungel, R Shrestha, JC Steel Current Cancer Drug Targets 17 (8), 698-706, 2017 | 67 | 2017 |
| FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis. BS Tan, M Anaka, S Deb, C Freyer, LM Ebert, AC Chueh, S Al-Obaidi, ... Oncotarget 5 (1), 264, 2014 | 59 | 2014 |
| Identifying and targeting determinants of melanoma cellular invasion A Jayachandran, P Prithviraj, PH Lo, M Walkiewicz, M Anaka, BL Woods, ... Oncotarget 7 (27), 41186, 2016 | 53 | 2016 |
| Pregnancy associated plasma protein-A links pregnancy and melanoma progression by promoting cellular migration and invasion P Prithviraj, M Anaka, SJ McKeown, M Permezel, M Walkiewicz, J Cebon, ... Oncotarget 6 (18), 15953, 2015 | 43 | 2015 |
| Transketolase-like 1 ectopic expression is associated with DNA hypomethylation and induces the Warburg effect in melanoma cells A Jayachandran, PH Lo, AC Chueh, P Prithviraj, R Molania, ... BMC cancer 16, 1-15, 2016 | 42 | 2016 |
| Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells K Woods, A Pasam, A Jayachandran, MC Andrews, J Cebon Frontiers in oncology 4, 367, 2014 | 41 | 2014 |
| Two-photon dual imaging platform for in vivo monitoring cellular oxidative stress in liver injury H Wang, R Zhang, KR Bridle, A Jayachandran, JA Thomas, W Zhang, ... Scientific Reports 7 (1), 45374, 2017 | 40 | 2017 |
| TNF‑α‑mediated epithelial‑to‑mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinoma R Shrestha, KR Bridle, DHG Crawford, A Jayachandran Molecular Medicine Reports 21 (4), 1849-1860, 2020 | 27 | 2020 |
| Combined inhibition of TGF-β1-induced EMT and PD-L1 silencing re-sensitizes hepatocellular carcinoma to sorafenib treatment R Shrestha, P Prithviraj, KR Bridle, DHG Crawford, A Jayachandran Journal of Clinical Medicine 10 (9), 1889, 2021 | 26 | 2021 |
| Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma IT Huang, B Dhungel, R Shrestha, KR Bridle, DHG Crawford, ... Expert Opinion on Investigational Drugs 28 (1), 7-18, 2019 | 23 | 2019 |
| Seek and destroy: targeted adeno-associated viruses for gene delivery to hepatocellular carcinoma B Dhungel, A Jayachandran, CJ Layton, JC Steel Drug Delivery 24 (1), 289-299, 2017 | 20 | 2017 |
| Immune checkpoint molecules are regulated by transforming growth factor (TGF)-β1-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma R Shrestha, KR Bridle, DHG Crawford, A Jayachandran International Journal of Medical Sciences 18 (12), 2466, 2021 | 18 | 2021 |
| Promoter hypomethylation of NY-ESO-1, association with clinicopathological features and PD-L1 expression in non-small cell lung cancer AC Chüeh, MS Liew, PA Russell, M Walkiewicz, A Jayachandran, ... Oncotarget 8 (43), 74036, 2017 | 17 | 2017 |
